Wczytywanie kursów wyceny...
Prognoza
Średnia cena docelowa analityków wynosi 57,77 € (+1694,10%). Mediana wynosi 36,88 € (+1045,34%).
| Kupuj |
5 |
| Trzymaj |
13 |
| Sprzedaj |
2 |
Wiadomości Przejdź do aktualności
Tilray Brands converts $12 million of debt into 2,841,650 common shares
Tilray Brands carried out private transactions between August 31 and September 8 and issued 2,841,650 unregistered common shares in exchange for $12 million principal amount of its 5.20% convertible senior notes due June 15, 2027. The transactions were with independent third parties and relied on the Section 3(a)(9) exemption of the Securities Act of 1933. » Więcej na de.investing.com
Tilray Brands to buy HelloMD and build vertically integrated medical cannabis platform in Canada
Tilray Brands announced on June 29 that it will acquire HelloMD's Canadian medical cannabis assets after winning a court-approved sale process. The deal pairs HelloMD's digital telehealth and patient engagement platform with Tilray's cultivation, clinical expertise and national fulfillment to create a connected pathway for patients and practitioners. Tilray highlighted opportunities to expand into adjacent wellness categories like sleep and pain support; financial terms were not disclosed. Shares of Tilray are down more than 50% year-to-date. » Więcej na finance.yahoo.com
Dane finansowe spółki
| (EUR) | maj 2026 | YoY |
|---|---|---|
| Przychody | 241,83 mln | 10,93% |
| Zysk brutto | 72,39 mln | 11,49% |
| Zysk netto | -42,55 mln | 97,24% |
| EBITDA | 12,75 mln | 100,78% |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 358,73 mln € |
Liczba akcji | 111,83 mln |
Maksimum/minimum z 52 tygodni | 20,62 € - 3,15 € |
| Dywidendy | Nie |
Beta | 1,92 |
C/Z (PE Ratio) | -2,71 |
PEG (PEG Ratio) | -0,01 |
C/WK (PB Ratio) | 0,25 |
C/S (PS Ratio) | 0,35 |
Profil spółki
| Nazwa | TILRAY BRANDS NEW O.N. |
| CEO | Irwin David Simon |
| Siedziba | Leamington,
on Stany Zjednoczone |
| Strona internetowa | |
| Sektor | Ochrona zdrowia |
| Branża | Biotechnologia |
| Pracownicy | 3595 |